Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
ACS Medicinal Chemistry Letters
|
October 18, 2019
Dual Inhibition of TAF1 and BET Bromodomains from the BI-2536 Kinase Inhibitor Scaffold
David Remillard, Dennis L Buckley, Hyuk-Soo Seo, et al.
Journal of the American Chemical Society
|
June 2, 2023
Correction to "Targeted Protein Degradation by Electrophilic PROTACs that Stereoselectively and Site-Specifically Engage DCAF1"
Yongfeng Tao, David Remillard, Ekaterina V Vinogradova, et al.
Journal of the American Chemical Society
|
September 28, 2022
Targeted Protein Degradation by Electrophilic PROTACs that Stereoselectively and Site-Specifically Engage DCAF1
Yongfeng Tao, David Remillard, Ekaterina V Vinogradova, et al.
Angewandte Chemie (International Ed. in English)
|
April 19, 2017
Degradation of the BAF Complex Factor BRD9 by Heterobifunctional Ligands
David Remillard, Dennis L Buckley, Joshiawa Paulk, et al.
Angewandte Chemie (International Ed. in English)
|
November 1, 2023
Chemical Proteomic Discovery of Isotype-Selective Covalent Inhibitors of the RNA Methyltransferase NSUN2
Yongfeng Tao, Jan G Felber, Zhongyu Zou, et al.
Chemmedchem
|
November 19, 2016
Assessment of Bromodomain Target Engagement by a Series of BI2536 Analogues with Miniaturized BET-BRET
Luke W Koblan, Dennis L Buckley, Christopher J Ott, et al.
Nature Structural & Molecular Biology
|
July 24, 2023
Collateral lethality between HDAC1 and HDAC2 exploits cancer-specific NuRD complex vulnerabilities
Yuxiang Zhang, David Remillard, Ugoma Onubogu, et al.
Science Advances
|
April 29, 2022
A novel β-catenin/BCL9 complex inhibitor blocks oncogenic Wnt signaling and disrupts cholesterol homeostasis in colorectal cancer
Helen Tanton, Tomasz Sewastianik, Hyuk-Soo Seo, et al.
ACS Chemical Biology
|
September 13, 2021
Chemoproteomics Enabled Discovery of Selective Probes for NuA4 Factor BRD8
David Remillard, Nikolas A Savage, Alexia T Kedves, et al.
Elife
|
November 16, 2018
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma
Gerard L Brien, David Remillard, Junwei Shi, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
ACS Medicinal Chemistry Letters
|
October 18, 2019
Dual Inhibition of TAF1 and BET Bromodomains from the BI-2536 Kinase Inhibitor Scaffold
David Remillard, Dennis L Buckley, Hyuk-Soo Seo, et al.
Journal of the American Chemical Society
|
June 2, 2023
Correction to "Targeted Protein Degradation by Electrophilic PROTACs that Stereoselectively and Site-Specifically Engage DCAF1"
Yongfeng Tao, David Remillard, Ekaterina V Vinogradova, et al.
Journal of the American Chemical Society
|
September 28, 2022
Targeted Protein Degradation by Electrophilic PROTACs that Stereoselectively and Site-Specifically Engage DCAF1
Yongfeng Tao, David Remillard, Ekaterina V Vinogradova, et al.
Angewandte Chemie (International Ed. in English)
|
April 19, 2017
Degradation of the BAF Complex Factor BRD9 by Heterobifunctional Ligands
David Remillard, Dennis L Buckley, Joshiawa Paulk, et al.
Angewandte Chemie (International Ed. in English)
|
November 1, 2023
Chemical Proteomic Discovery of Isotype-Selective Covalent Inhibitors of the RNA Methyltransferase NSUN2
Yongfeng Tao, Jan G Felber, Zhongyu Zou, et al.
Chemmedchem
|
November 19, 2016
Assessment of Bromodomain Target Engagement by a Series of BI2536 Analogues with Miniaturized BET-BRET
Luke W Koblan, Dennis L Buckley, Christopher J Ott, et al.
Nature Structural & Molecular Biology
|
July 24, 2023
Collateral lethality between HDAC1 and HDAC2 exploits cancer-specific NuRD complex vulnerabilities
Yuxiang Zhang, David Remillard, Ugoma Onubogu, et al.
Science Advances
|
April 29, 2022
A novel β-catenin/BCL9 complex inhibitor blocks oncogenic Wnt signaling and disrupts cholesterol homeostasis in colorectal cancer
Helen Tanton, Tomasz Sewastianik, Hyuk-Soo Seo, et al.
ACS Chemical Biology
|
September 13, 2021
Chemoproteomics Enabled Discovery of Selective Probes for NuA4 Factor BRD8
David Remillard, Nikolas A Savage, Alexia T Kedves, et al.
Elife
|
November 16, 2018
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma
Gerard L Brien, David Remillard, Junwei Shi, et al.
Page
of 2